Bromopride (INN) is a dopamine antagonist with prokinetic properties widely used as an antiemetic, closely related to metoclopramide.

The manufacturer also claims it is valuable in, among other indications, hiccups and gastrointestinal adverse effects of radiation therapy.

Bromopride is generally well tolerated; the most common adverse effects of its use are somnolence and fatigue.

Bromopride may rarely cause extrapyramidal symptoms and, as with metoclopramide, may increase prolactin levels.

It is marketed in Brazil by Sanofi-Synthélabo under the trade name Digesan, by LIBBS under the name Plamet, and as a generic drug.